Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
More precise phenotype classification that captures the disease course and type is essential if the benefit of genotypic data for predicting clinical variability is to be assessed, which was considered in the development of the Montreal classification of IBD (1).
The Montreal Classification of Inflammatory Bowel Disease (IBD) presents several limitations when it comes to classifying children. It does not adequately account for the dynamic characteristics of pediatric disease phenotypes, such as changes in disease location and behavior over time, as well as growth failure. An international group of Pediatric Inflammatory Bowel Disease (IBD) experts gathered in Paris, France, with the aim of advancing research in pediatric inflammatory bowel diseas…